The financial burden of cancer patients: time to stop averting our eyes. (Q53598476)

16 May 2018

title

The financial burden of cancer patients: time to stop averting our eyes. (English)

1 reference

16 May 2018

author name string

Barry R Meisenberg

series ordinal

1

1 reference

16 May 2018

publication date

26 February 2015

1 reference

16 May 2018

Supportive Care in Cancer

published in

1 reference

16 May 2018

volume

23

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

1201-1203

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s00520-015-2664-2

exact match

0 references

cites work

Dido, queen of Carthage: Léonard Limosin

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Cents and sensitivity--teaching physicians to think about costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Full disclosure--out-of-pocket costs as side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Self-reported financial burden and satisfaction with care among patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Patient-oncologist cost communication, financial distress, and medication adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Patients' expectations about effects of chemotherapy for advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Financial and family burden associated with cancer treatment in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-015-2664-2

Economist: It's time for tough choices on US health costs.

21 January 2018

1 reference

12 December 2020

Cancer therapy costs influence treatment: a national survey of oncologists

1 reference

12 December 2020

Medical costs and productivity losses of cancer survivors--United States, 2008-2011.

1 reference

12 December 2020

Overcoming barriers to discussing out-of-pocket costs with patients

1 reference

12 December 2020

Communication about high-cost drugs in oncology--the patient view

1 reference

12 December 2020

10.1007/S00520-015-2664-2

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25711655

1 reference

16 May 2018